Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia
D Marin - Hematology 2010, the American Society of …, 2012 - ashpublications.org
Imatinib has been the preferred initial therapy for newly diagnosed chronic myeloid
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
[PDF][PDF] Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia
D Marin - Hematology, 2012 - scholar.archive.org
Imatinib has been the preferred initial therapy for newly diagnosed chronic myeloid
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
[PDF][PDF] Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia
D Marin - Hematology, 2012 - redbook.streamliners.co.nz
Imatinib has been the preferred initial therapy for newly diagnosed chronic myeloid
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia
D Marin - Hematology. American Society of Hematology …, 2012 - pubmed.ncbi.nlm.nih.gov
Imatinib has been the preferred initial therapy for newly diagnosed chronic myeloid
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia.
D Marin - … . American Society of Hematology. Education Program, 2012 - europepmc.org
Imatinib has been the preferred initial therapy for newly diagnosed chronic myeloid
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia.
D Marin - Hematology/the Education Program of the …, 2012 - mdanderson.elsevierpure.com
Imatinib has been the preferred initial therapy for newly diagnosed chronic myeloid
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
[PDF][PDF] Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia
D Marin - Hematology, 2012 - redbook.streamliners.co.nz
Imatinib has been the preferred initial therapy for newly diagnosed chronic myeloid
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …
leukemia patients for the past 10 years. Recently, other, possibly better, tyrosine kinase …